That's when its first-quarter results will be published.

The U.S. pharmaceutical market size was valued at USD 520.4 billion in 2025 and is predicted to hit around USD 965 billion by ...

Chongqing Claruvis Pharmaceutical Co., Ltd. recently announced that the China's National Medical Products Administration (NMPA) has approved its Retoxin® (recombinant botulinum toxin type A, project ...

Smaller acquisitions and disciplined pricing are proving to be big benefits to a wider number of companies ...

Apr 27, 2026--Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that th ...

Artios Pharma collected $115 million from an oversubscribed series D that will support its growing ambitions for its pipeline of DNA damage response (DDR)-targeting cancer prospects. The biotech is ...

The third quarter was a pivotal period for both the biotech and pharmaceutical sectors, with regulatory developments and an increase in business deals shaping the landscape for the industries. Public ...

In today's Pharmaceutical Executive Daily, we cover Sun Pharma's $11.75 billion acquisition of Organon and IMG Pharma's move ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Indian generic medicines giant Sun Pharmaceutical Industries is buying the women’s health company Organon in a deal worth $11 ...

Sun Pharma will pay $14.00 per share cash for Organon, targeting early-2027 close subject to regulatory and shareholder ...